Open access
Open access
Powered by Google Translator Translator

RCT | Efficacy and safety of azithromycin vs. placebo to treat lower respiratory tract infections associated with low procalcitonin.

16 Dec, 2022 | 13:30h | UTC

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text) 

Commentary: Study Evaluates Biomarker to Help Curb Unnecessary Antibiotic Use: Placebo Worse Than Antibiotics After 5 Days, But Similar at Day 11 – Duke Health

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.